Actively Recruiting

Phase Not Applicable
Age: 25Years - 49Years
FEMALE
Healthy Volunteers
NCT05385406

HPV Screening With Triage by HPV Genotyping Versus Visual Inspection With Acetic Acid

Led by Prof. Patrick Petignat · Updated on 2024-05-09

5500

Participants Needed

2

Research Sites

186 weeks

Total Duration

On this page

Sponsors

P

Prof. Patrick Petignat

Lead Sponsor

U

University Hospital, Geneva

Collaborating Sponsor

AI-Summary

What this Trial Is About

Cervical cancer is the leading cause of cancer death among women in sub-Saharan Africa, despite the existence of effective prevention and screening methods. Because vaccination rates against human papillomavirus (causing nearly all cervical cancers) are still insufficient in some low-resource countries, early detection and treatment of cervical lesions at risk of progressing to cancer are crucial components of cervical cancer control. Therefore, it is essential to find the most reliable and appropriate screening strategy in the context of low-resource countries in order to identify women in need of treatment and thus prevent the development of cervical cancer. The objective of our study is to compare two different methods of cervical cancer screening adapted to low-resource settings, in two study centers in Cameroon.

CONDITIONS

Official Title

HPV Screening With Triage by HPV Genotyping Versus Visual Inspection With Acetic Acid

Who Can Participate

Age: 25Years - 49Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • HIV-negative women aged 30-49 years
  • HIV-positive women aged 25-49 years
  • Ability to understand study procedures and voluntarily sign informed consent
Not Eligible

You will not qualify if you...

  • Pregnancy at the time of screening
  • Previous hysterectomy
  • Known cervical cancer
  • Symptoms of cervical cancer such as metrorrhagia or known pelvic mass
  • Conditions interfering with visualization of the cervix
  • Severe pre-existing medical conditions like advanced cancer or terminal renal failure
  • Inability to comply with the study protocol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Dschang Annex Regional Hospital

Dschang, Menoua, Cameroon

Actively Recruiting

2

Bafoussam Regional Hospital

Bafoussam, Mifi, Cameroon

Not Yet Recruiting

Loading map...

Research Team

P

Patrick Petignat, PD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here